Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Assets (2020 - 2025)

Harmony Biosciences Holdings' Return on Assets history spans 6 years, with the latest figure at 0.13% for Q4 2025.

  • For Q4 2025, Return on Assets fell 4.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 0.13%, down 4.0%, while the annual FY2025 figure was 0.14%, 4.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.13% at Harmony Biosciences Holdings, down from 0.17% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.27% in Q3 2022 and bottomed at 0.02% in Q1 2021.
  • The 5-year median for Return on Assets is 0.14% (2022), against an average of 0.13%.
  • The largest annual shift saw Return on Assets increased 24bps in 2022 before it fell -19bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.08% in 2021, then surged by 72bps to 0.14% in 2022, then rose by 12bps to 0.16% in 2023, then increased by 4bps to 0.17% in 2024, then fell by -24bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Return on Assets are 0.13% (Q4 2025), 0.17% (Q3 2025), and 0.18% (Q2 2025).